Ausdal Financial Partners, Inc. Bluebird Bio, Inc. Transaction History
Ausdal Financial Partners, Inc.
- $897 Million
- Q3 2024
A detailed history of Ausdal Financial Partners, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 12,513 shares of BLUE stock, worth $97,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,513
Previous 12,513
-0.0%
Holding current value
$97,726
Previous $12,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
151Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$81.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$36.6 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$36.4 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$30 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $602M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...